SAN DIEGO, June 12, 2017 — Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary Kannaway, LLC, the first hemp lifestyle network to offer phyto-cannabinoid botanical products, is recognizing its first Brand Ambassadors to reach the Company’s National Director Rank.
Jeff and Debbie Lessard are the first Brand Ambassadors in Kannaway® history to earn this status, which requires achieving a minimum of $500,000 in sales per month. Jeff and Debbie Lessard began their career with Kannaway® in January of 2016, and have since then been recognized numerous times for their efforts to educate others about Kannaway’s® cannabidiol (CBD) hemp oil products.
“Jeff and Debbie are a shining example of the type of success we hope to see all of our Brand Ambassadors achieve. Jeff has worked tirelessly to achieve this result. His unrelenting commitment and drive set an example we all can learn from,” said Kannaway® CEO Blake Schroeder. “We are a family-focused company driven to enhance the wellbeing of others worldwide. I am proud to have Jeff and his family on our team.”
“After learning about the therapeutic benefits of CBD, it has been a pleasure seeing the impact these products have on people’s lives,” Jeff Lessard said. “I am honored to be a part of the Kannaway® family.”
About Kannaway, LLC
Kannaway, LLC, is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.
About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.